What Is Obesity? Definition for Peptide Research

Obesity Classification

By BMI

BMI (kg/m²)	Classification
18.5-24.9	Normal weight
25-29.9	Overweight
30-34.9	Class I Obesity
35-39.9	Class II Obesity
≥40	Class III (Severe) Obesity

BMI Limitations

BMI doesn’t account for:

Muscle mass
Fat distribution
Metabolic health
Ethnic variations

Obesity as a Disease

Modern Understanding

Obesity is recognized as a chronic disease by:

American Medical Association (2013)
World Health Organization
Obesity Medicine Association
Most medical organizations

Why “Disease” Matters

Removes moral judgment
Justifies medical treatment
Insurance coverage implications
Research funding

Causes of Obesity

Biology

Genetics (40-70% heritable)
Hormonal dysregulation
Gut microbiome
Metabolic adaptation

Environment

Food availability
Marketing of ultra-processed foods
Sedentary jobs and transport
Built environment

Behavior

Eating patterns
Physical activity
Sleep
Stress

The Reality

Obesity results from complex interactions—not simply “eating too much.” Biology often drives behavior.

Health Consequences

Increased Risk Of

System	Conditions
Metabolic	Type 2 diabetes, metabolic syndrome
Cardiovascular	Heart disease, stroke, hypertension
Cancer	Breast, colon, endometrial, others
Respiratory	Sleep apnea, asthma
Musculoskeletal	Osteoarthritis, back pain
Mental Health	Depression, anxiety
Other	NAFLD, GERD, infertility

Risk Reduction with Weight Loss

Even 5-10% weight loss significantly reduces:

Diabetes risk
Blood pressure
Cholesterol levels
Sleep apnea severity

Obesity Treatment Evolution

Historical Approaches

Diet and exercise (limited success long-term)
Behavioral therapy
Older medications (often withdrawn for safety)
Bariatric surgery (effective but invasive)

Modern Approach

Comprehensive Treatment:
├── Lifestyle modification (foundation)
├── Behavioral support
├── Pharmacotherapy (GLP-1 agonists)
└── Surgery (selected patients)

GLP-1 Agonists for Obesity

FDA-Approved Options

Drug	Brand	Weight Loss
Semaglutide 2.4mg	Wegovy	~15% average
Tirzepatide	Zepbound	~20% average
Liraglutide 3.0mg	Saxenda	~8% average

How They Work

Reduce appetite
Enhance satiety
Slow gastric emptying
Possible metabolic effects

Efficacy Context

These represent the most effective non-surgical obesity treatments ever developed.

Weight Regain Challenge

The Pattern

Weight loss with treatment
Physiological adaptations favor regain
Stopping medication → weight regain
Biology, not willpower

Why This Happens

Hormonal changes (increased hunger hormones)
Metabolic adaptation (reduced energy expenditure)
Set point theory (body defends higher weight)

Implication

Long-term treatment often necessary, like other chronic diseases.

Frequently Asked Questions

Is obesity really a disease or lifestyle choice?

Major medical organizations classify obesity as a chronic disease based on evidence of biological dysregulation. While behavior matters, genetics and biology heavily influence both appetite and metabolism. Most people with obesity have tried repeatedly to lose weight.

Why is obesity treatment now considered lifelong?

Similar to hypertension or diabetes, obesity involves chronic biological changes. When treatment stops, the underlying biology reasserts itself. This doesn’t represent failure—it reflects disease management reality.

Do GLP-1 agonists work for everyone?

Response varies. In trials, most patients lose weight, but amount varies from 5% to 25%+. About 10-15% may not respond well. Factors affecting response are still being studied.

Obesity